Simulations Plus, Inc. (SLP)
Oct 6, 2026 - SLP was delisted (reason: acquired by Altaris)
18.50
0.00 (0.00%)
Inactive · Last trade price on Oct 5, 2026
Simulations Plus Revenue
Simulations Plus had revenue of $21.89M in the quarter ending May 31, 2026, with 7.48% growth. This brings the company's total for the last twelve months to $82.06M, up 2.08% year-over-year. In the fiscal year ending August 31, 2025, Simulations Plus had annual revenue of $79.18M with 13.09% growth.
Revenue (ttm)
$82.06M
Revenue Growth
+2.08%
P/S Ratio
4.56
Revenue / Employee
$385,249
Employees
213
Market Cap
374.16M
Revenue by Segment
Fiscal year ended Aug 31, 2025 See the full Simulations Plus breakdown
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Aug 31, 2025 | 79.18M | 9.17M | 13.09% |
| Aug 31, 2024 | 70.01M | 10.44M | 17.52% |
| Aug 31, 2023 | 59.58M | 5.67M | 10.52% |
| Aug 31, 2022 | 53.91M | 7.44M | 16.01% |
| Aug 31, 2021 | 46.47M | 4.88M | 11.73% |
| Aug 31, 2020 | 41.59M | 7.62M | 22.43% |
| Aug 31, 2019 | 33.97M | 4.30M | 14.51% |
| Aug 31, 2018 | 29.67M | 5.53M | 22.90% |
| Aug 31, 2017 | 24.14M | 4.17M | 20.86% |
| Aug 31, 2016 | 19.97M | 1.66M | 9.05% |
| Aug 31, 2015 | 18.31M | 6.85M | 59.80% |
| Aug 31, 2014 | 11.46M | 1.39M | 13.80% |
| Aug 31, 2013 | 10.07M | 622.16K | 6.58% |
| Aug 31, 2012 | 9.45M | 709.87K | 8.12% |
| Aug 31, 2011 | 8.74M | -1.97M | -18.42% |
| Aug 31, 2010 | 10.71M | 1.57M | 17.16% |
| Aug 31, 2009 | 9.14M | 175.30K | 1.95% |
| Aug 31, 2008 | 8.97M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
SLP News
- 10 days ago - Johnson Fistel Investigates Simulations Plus Following Revenue Guidance Cut and Accounting Disclosures - GlobeNewsWire
- 24 days ago - Simulations Plus Announces Funded Partnership with Global Pharmaceutical Company to Advance AI-Enabled QSP Model Development with Turin - Business Wire
- 26 days ago - Simulations Plus Announces Completion of Acquisition by Altaris - Business Wire
- 6 weeks ago - Simulations Plus Expands FDA Adoption of ADMET Predictor® with New Licenses for the Cosmetics Regulatory Science Branch - Business Wire
- 6 weeks ago - Simulations Plus Transcript: Status update - Transcripts
- 2 months ago - Simulations Plus Proxy statement: Proxy filing - Filings
- 2 months ago - Simulations Plus Announces Expiration of Hart-Scott-Rodino Waiting Period for Pending Acquisition by Altaris - Business Wire
- 3 months ago - Simulation Plus, Inc. Securities Fraud Investigation - Robbins LLP is Investigating Investor Losses in SLP Due to Possible Violations of Securities Laws - Newsfile Corp